Paclitaxel resistance in untransformed human mammary epithelial cells is associated with an aneuploidy-prone phenotype
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603936.pdf
Reference29 articles.
1. Asakawa K, Kume K, Kanai M, Goshima T, Miyahara K, Dhut S, Tee WW, Hirata D, Toda T (2006) The V260I mutation in fission yeast alpha-tubulin Atb2 affects microtubule dynamics and EB1-Mal3 localization and activates the Bub1 branch of the spindle checkpoint. Mol Biol Cell 17: 1421–1435
2. Banerjee A (2002) Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Biochem Biophys Res Commun 293: 598–601
3. Branch P, Masson M, Aquilina G, Bignami M, Karran P (2000) Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells. Oncogene 19: 3138–3145
4. Carles G, Braguer D, Dumontet C, Bourgarel V, Goncalves A, Sarrazin M, Rognoni JB, Briand C (1999) Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs. Br J Cancer 80: 1162–1168
5. Colella G, Marchini S, D'Incalci M, Brown R, Broggini M (1999) Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents. Br J Cancer 80: 338–343
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chromosomal Instability as Enabling Feature and Central Hallmark of Breast Cancer;Breast Cancer: Targets and Therapy;2023-03
2. Pharmacodynamic modeling of synergistic birinapant/paclitaxel interactions in pancreatic cancer cells;BMC Cancer;2020-10-23
3. PARP inhibition causes premature loss of cohesion in cancer cells;Oncotarget;2017-10-16
4. PARP inhibition causes premature loss of cohesion in cancer cells;2017-06-22
5. A tumor deconstruction platform identifies definitive end points in the evaluation of drug responses;Oncogene;2015-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3